Research and Health webinars

Join Prof Albena Dinkova-Kostova, Professor of Chemical Biology at the University of Dundee School of Medicine (UK), at the usual time of 1pm.

Join the webinar to find out more and ask your questions about…

• How EBS skin cells respond to inflammation
• The development of strategies for protection against chronic conditions
• The role of Nrf2, a protein involved in responses to inflammation, and how it could be targeted in EBS

Register for our march webinar

More about this webinar’s speaker:

Prof Albena Dinkova-Kostova is a Professor of Chemical Biology at the University of Dundee School of Medicine (UK). She graduated in Biochemistry and Microbiology from Sofia University (Bulgaria) and obtained her PhD degree in Biochemistry and Biophysics from Washington State University (USA). She subsequently trained in Pharmacology at Johns Hopkins University School of Medicine (USA), where she continues to hold an Adjunct Professor position. She joined the University of Dundee in 2007 as a Research Councils UK Academic Fellow and a research group leader. Her group collaborates with basic scientists and clinicians, and with the pharmaceutical industry. In her research, at the interface of Chemical Biology and Medicine, she is committed to understanding how cells and organisms respond to oxidative, inflammatory, and metabolic stress, and is working towards development of strategies for protection against chronic disease. Over the past seven years, she has been named among the top influential academics in Clarivate’s Highly Cited Researchers lists.

Join Dr Laura De Rosa, associate professor of applied biology at the University of Modena and Reggio Emilia (Italy), at the usual time of 1pm.

Join the webinar to find out more and ask your questions about…

• Dominant inheritance of EB – from one parent with EB (not two unaffected parents as in recessive inheritance).
• How gene editing can work for dominant conditions.
• Advances in gene editing techniques and applying them to restore EBS skin strength.

Register for our april webinar

More about this webinar’s speaker:

Dr Laura De Rosa is an associate professor of applied biology at the University of Modena and Reggio Emilia, Italy. Her research focuses on epithelial stem cells and the development of innovative gene-editing strategies for rare genetic disorders affecting epithelial tissues, with a particular emphasis on Epidermolysis Bullosa. She has coordinated multiple clinical studies in gene therapy for Epidermolysis Bullosa and currently leads translational research projects aimed at advancing personalized gene-therapy approaches toward future clinical applications.

Join Dr Matthew Caley, Senior Lecturer in Cell Biology at Queen Mary University of London (UK), at the usual time of 1pm.

Join the webinar to find out more and ask your questions about…

• What is an EB model?
• How models of EB skin are created in the laboratory
• The importance of testing potential therapies in models before giving them to people in clinical trials

Register for our May webinar

More about this webinar’s speaker:

Dr Matthew Caley is a Senior Lecturer in Cell Biology at the Blizard Institute, Queen Mary University of London (QMUL), UK. He has more than a decade of experience in skin research, matrix biology and generating in vitro skin models. He is currently running pre-clinical trials focused on a range of different skin diseases including JEB.

Join Dr Emily Gorrell, Assistant Professor of Dermatology at the University of Colorado, at the later time of 8pm.

Join the webinar to find out more and ask your questions about…

• Gene therapy carried out on cells outside the body
• Clinical trials on gene therapy
• Current progress

Register for our June webinar

More about this webinar’s speaker:

Dr Emily Gorell is an Assistant Professor of Dermatology at the University of Colorado, where she specializes in the treatment of patients with blistering diseases and complex medical dermatology and serves as the Associate Director of Clinical Research. Dr. Gorell has been involved in researching treatments for epidermolysis bullosa for over 15 years, particularly gene therapies. She sees patients at both the Children’s Hospital of Colorado and the University of Colorado Hospital, with a focus on transition of care and treatment of adults with EB and other complex skin conditions.